MEDIPOST Co., Ltd.
- Country
- 🇰🇷South Korea
- Ownership
- Public
- Established
- 2000-01-01
- Employees
- 290
- Market Cap
- -
- Website
- http://www.medi-post.co.kr
Clinical Trials
18
Trial Phases
4 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (17 trials with phase data)• Click on a phase to view related trials
Evaluation Safety and Explore Efficacy Long-term Follow-up Study on Subjects Receiving SMUP-IA-01 or Active Control
- Conditions
- Knee Osteoarthritis
- Interventions
- Biological: SMUP-IA-01(low-dose)Biological: SMUP-IA-01(mid-dose)Drug: High Hyal Plus
- First Posted Date
- 2025-01-29
- Last Posted Date
- 2025-02-07
- Lead Sponsor
- Medipost Co Ltd.
- Target Recruit Count
- 84
- Registration Number
- NCT06798727
- Locations
- 🇰🇷
Seoul Nation University Bundang Hospital, Gyeonggi-do, Korea, Republic of
🇰🇷Gangnam Severance Hospital, Seoul, Korea, Republic of
🇰🇷Korea University Anam Hospita, Seoul, Korea, Republic of
Clinical Trial to Evaluate Efficacy and Safety of SMUP-IA-01 in Patients With Knee Osteoarthritis
- Conditions
- Knee Osteoarthritis
- Interventions
- Biological: SMUP-IA-01(low dose)Biological: SMUP-IA-01(mid dose)Drug: Active Control Group Sodium chloride
- First Posted Date
- 2022-01-10
- Last Posted Date
- 2025-02-05
- Lead Sponsor
- Medipost Co Ltd.
- Target Recruit Count
- 94
- Registration Number
- NCT05182034
- Locations
- 🇰🇷
Seoul Nation University Bundang Hospital, Gyeonggi-do, Korea, Republic of
🇰🇷Gangnam Severance Hospital, Seoul, Korea, Republic of
🇰🇷Korea University Anam Hospita, Seoul, Korea, Republic of
Follow-up Safety and Efficacy Evaluation on Subjects Who Completed Phase I Clinical Trial
- Conditions
- Knee Osteoarthritis
- First Posted Date
- 2020-04-09
- Last Posted Date
- 2023-03-15
- Lead Sponsor
- Medipost Co Ltd.
- Target Recruit Count
- 12
- Registration Number
- NCT04339504
- Locations
- 🇰🇷
Seoul national University Hospital, Seoul, Jongno-gu, Korea, Republic of
Evaluate Safety and Explore Efficacy of SMUP-IA-01 in Patients With Knee Osteoarthritis
- Conditions
- Knee Osteoarthritis
- First Posted Date
- 2019-07-30
- Last Posted Date
- 2021-02-24
- Lead Sponsor
- Medipost Co Ltd.
- Target Recruit Count
- 12
- Registration Number
- NCT04037345
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Jongno-gu, Korea, Republic of
Follow-up Study of Safety and Efficacy in Subjects Who Completed PNEUMOSTEM® Phase II (MP-CR-012) Clinical Trial
- Conditions
- Bronchopulmonary DysplasiaBPD
- Interventions
- Biological: normal salineBiological: PNEUMOSTEM®
- First Posted Date
- 2019-07-01
- Last Posted Date
- 2025-02-07
- Lead Sponsor
- Medipost Co Ltd.
- Target Recruit Count
- 60
- Registration Number
- NCT04003857
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
🇰🇷Samsung Medical Center, Seoul, Korea, Republic of
- Prev
- 1
- 2
- 3
- 4
- Next